ResultsIQ › Latest results › Fermenta Biotech Limited
Fermenta Biotech Limited Q2 FY27 results deck summary
NSE: FERMENTA · BSE: 506414
Results deck of 6 Nov 2026, summarised by AI from the filing.
Q2 FY27 revenue ₹135.8 cr, up 8% QoQ but level YoY, as animal nutrition prices reset and net debt fell below ₹3 cr.
Key takeaways
- Q2 revenue Consolidated revenue ₹135.8 cr, up 0.1% YoY and up 8% QoQ, with EBITDA ₹23.2 cr and PAT ₹9.4 cr.
- Guidance VITADEE Green® capacity is expected from Q2FY28 and Calcifediol ready for regulatory approvals by end-FY27.
- Human Nutrition Human Nutrition revenue ₹163 cr in H1FY27, up 2% YoY, lifting its share of revenue to 62% from 57%.
- Animal nutrition Animal nutrition revenue fell to ₹22 cr from ₹46 cr, with volumes down 31% and realisations down 35% YoY.
Fermenta Biotech Limited Q2 FY27 results
As filed: Revenue ₹117 cr, EBITDA ₹24.1 cr, PAT ₹14.0 cr, EBITDA margin 20.6%.
Not scored. No result for the same quarter last year.
Earlier results and the share price after them
- Q1 FY27: Revenue ₹112 cr, EBITDA ₹23.0 cr, PAT ₹15.0 cr, EBITDA margin 20.6%. Not scored. No result for the same quarter last year. Share price after the results: −11.7% in 30 days (Nifty 500: −3.3%).
Past price moves after results do not indicate future moves. Not a recommendation.
Fermenta Biotech Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Results deck (6 Nov 2026), Results press release (5 Nov 2026)
- Q1 FY27: Results deck (11 Aug 2026), Results press release (11 Aug 2026)
- Q4 FY26: Results deck (26 May 2026), Results press release (26 May 2026)
- Q3 FY26: Results deck (11 Feb 2026), Results press release (9 Feb 2026)
- Q2 FY26: Results deck (12 Nov 2025), Results press release (11 Nov 2025)
- Q1 FY26: Results deck (13 Aug 2025)
- Q4 FY25: Results deck (4 Jun 2025), Results press release (28 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.